Berretta Massimiliano, Dal Lago Lissandra, Tinazzi Mattia, Ronchi Andrea, La Rocca Gaspare, Montella Liliana, Di Francia Raffaele, Facchini Bianca Arianna, Bignucolo Alessia, Montopoli Monica
Department of Clinical and Experimental Medicine, University of Messina, 98122 Messina, Italy.
Integrative Medicine Research Group (IMRG), Noceto, 43015 Parma, Italy.
Cancers (Basel). 2022 Oct 23;14(21):5203. doi: 10.3390/cancers14215203.
CAM is used by about 40% of cancer patients in Western Countries, with peaks of 80% for breast cancer patients. Cancer patients use CAM to boost immune function, to control cancer symptoms and treatment-related side effects, and to improve health-related quality of life (HR-QoL) and survival. Unfortunately, self-prescription of natural remedies in cancer patients can lead to unexpected toxicities and can reduce the effectiveness of cancer therapy. Although CAM usually refers to all the "natural or organic" products/methods that are generally considered less toxic, there are concerns about drug interactions, especially in patients participating in clinical trials with experimental agents. Despite the claims of the promising and potential benefits made by prescribers, many CAMs lack clear scientific evidence of their safety and efficacy. Given the widespread use of CAM-both clearly declared and overt-in this review, we focused on the most important known data on the risk of interactions between biologics and oncology drugs with the goal of opening up CAM in accordance with the meaning of integrative medicine.
在西方国家,约40%的癌症患者使用补充替代医学(CAM),乳腺癌患者的使用比例高达80%。癌症患者使用CAM来增强免疫功能、控制癌症症状和治疗相关的副作用,并改善健康相关生活质量(HR-QoL)和生存率。不幸的是,癌症患者自行开具天然药物可能会导致意外的毒性反应,并降低癌症治疗的效果。尽管CAM通常指所有一般被认为毒性较小的“天然或有机”产品/方法,但人们担心药物相互作用,尤其是在参与使用实验性药物的临床试验的患者中。尽管开处方者声称CAM有前景且有潜在益处,但许多CAM缺乏关于其安全性和有效性的明确科学证据。鉴于CAM无论是明确宣称的还是明显的广泛使用,在本综述中,我们聚焦于生物制剂与肿瘤药物之间相互作用风险的最重要已知数据,目的是按照整合医学的意义来开放CAM。